Primary dysmenorrhea.
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
Primary dysmenorrhea, characterized by painful menstruation due to increased prostaglandins, affects up to 90% of women and is managed with NSAIDs and oral contraceptives, though some cases require further investigation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Primary dysmenorrhea is defined as cramping pain in the lower abdomen occurring just before or during menstruation, in the absence of other diseases such as endometriosis. Prevalence rates are as high as 90 percent. Initial presentation of primary dysmenorrhea typically occurs in adolescence. It is a common cause of absenteeism and reduced quality of life in women. The problem is often underdiagnosed and undertreated. Women with primary dysmenorrhea have increased production of endometrial prostaglandin, resulting in increased uterine tone and stronger, more frequent uterine contractions. A diagnostic evaluation is unnecessary in patients with typical symptoms and no risk factors for secondary causes. Nonsteroidal anti-inflammatory medications are the mainstay of treatment, with the addition of oral contraceptive pills when necessary. About 10 percent of affected women do not respond to these measures. It is important to consider secondary causes of dysmenorrhea in women who do not respond to initial treatment. Many alternative treatments (ranging from acupuncture to laparoscopic surgery) have been studied, but the supporting studies are small, with limited long-term follow-up.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- The Place of Cannabinoids in the Treatment of Gynecological Pain 2023
- Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study 2013
- Attributes and Barriers to Care of Pelvic Pain in University Women 2013
- Eotaxin levels in patients with primary dysmenorrhea 2018
Cited by (4)
- The Place of Cannabinoids in the Treatment of Gynecological Pain 2023
- Eotaxin levels in patients with primary dysmenorrhea 2018
- Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study 2013
- Attributes and Barriers to Care of Pelvic Pain in University Women 2013
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:10:24.024533+00:00
License: CC0
· commercial use OK